| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| Q53X46 | MHC class I antigen; | HLA-C; HLA-Cw; | NULL | 366 | human |
| Q9B0T5 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; NADH2 ndh2; | NULL | 347 | human |
| B4DIG0 | M-phase inducer phosphatase 2; cDNA FLJ53333, highly similar to M-phase inducer phosphatase 2 (EC 3.1.3.48); | CDC25B; | NP_001274445.1; | 516 | human |
| D3DPB9 | Nitric oxide synthase trafficker, isoform CRA_a; | NOSTRIN; | NULL | 400 | human |
| D6W5C8 | Uncharacterized protein; | FLJ31438; | NULL | 137 | human |
| G5E9R3 | 60S ribosomal protein L37a; Ribosomal protein L37a, isoform CRA_b; | RPL37A; | NULL | 58 | human |
| H9Q7X0 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| B1A4H2 | Chorionic somatomammotropin hormone 1; Chorionic somatomammotropin hormone 1 isoform 3; HCG1749481, isoform CRA_d; HCG1749481, isoform CRA_w; HCG1749481, isoform CRA_y; | CSH1; | NULL | 122 | human |
| C8YBX6 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| Q6WQV6 | Lymphotoxin alpha; Fragment; | LTA; | NULL | 66 | human |
| E5FQ58 | MHC class I antigen; MHC class II antigen; | HLA-B; HLA-DRB1; | NULL | 362 | human |
| D3DXF2 | Abhydrolase domain containing 11, isoform CRA_d; | ABHD11; | XP_006716207.1; | 202 | human |
| A0A087WT15 | Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13; | ALG13; | NULL | 61 | human |
| C9D6A9 | Cytochrome b; | CYTB; | NULL | 380 | human |
| E9LRJ2 | POU domain protein; | POU5F1P4; | NULL | 286 | human |
| Q14WI3 | NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3; Fragment; | NULL | NULL | 78 | human |
| A6ZFB0 | NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3; | ND2; | NULL | 347 | human |
| D3DVY6 | HCG39252, isoform CRA_a; | NULL | NULL | 161 | human |
| B1W861 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | NADH4; ND4; | NULL | 459 | human |
| B5M7S8 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | ND4; | NULL | 459 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |